Presence of hepatitis C (HCV) infection in Baby Boomers with Medicare is independently associated with mortality and resource utilisation

Alimentary Pharmacology and Therapeutics

Volumn 43, Issue 10, 2016, Pages 1060-1068

  Sayiner, M ^a   Wymer, M ^a   Golabi, P ^a   Ford, J ^b   Srishord, I ^a   Younossi, Z M ^a,b  

^a Betty and Guy Beatty Center for Integrated Research   (United States)

^b INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BABY BOOMER; BILLING AND CLAIMS; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; DISABLED PERSON; END STAGE RENAL DISEASE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ICD-9; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICARE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; AGE DISTRIBUTION; ANCESTRY GROUP; ECONOMICS; FACTUAL DATABASE; SEVERITY OF ILLNESS INDEX; SEX RATIO; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGE DISTRIBUTION; CONTINENTAL POPULATION GROUPS; DATABASES, FACTUAL; DISABLED PERSONS; FEMALE; HEALTH EXPENDITURES; HEPATITIS C; HUMANS; LENGTH OF STAY; MALE; MEDICARE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; UNITED STATES;

EID: 84961262233     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13592     Document Type: Article

References (32)

1. Younossi ZM, Otgonsuren M, Henry L, et al,. Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States. J Viral Hepat 2015; 22: 137-45.
2. Chak E, Talal AH, Sherman KE, Schiff ER, Saab S,. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int 2011; 31: 1090-101.
3. Younossi ZM, Stepanova M, Afendy M, Lam BP, Mishra A,. Knowledge about infection is the only predictor of treatment in patients with chronic hepatitis C. J Viral Hepat 2013; 20: 550-5.
4. Davis KL, Mitra D, Medjedovic J, Beam C, Rustgi V,. Direct economic burden of chronic hepatitis C virus in a United States managed care population. J Clin Gastroenterol 2011; 45: e17-24.
5. Stepanova M, Kanwal F, El-Serag HB, Younossi ZM,. Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States. Hepatology 2011; 53: 737-45.
6. Ghany MG, Strader DB, Thomas DL, Seeff LB,. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-74.
7. Coyle C, Viner K, Hughes E, et al,. Identification and linkage to care of HCV-infected persons in five health centers-Philadelphia, Pennsylvania, 2012-2014. MMWR Morb Mortal Wkly Rep 2015; 64: 459-63. Available at www.cdc.gov/mmwr/preview/mmwrhtml/mm6417a3.htm.
8. Menzin J, White LA, Nichols C, Deniz B,. The economic burden of advanced liver disease among patients with hepatitis C virus: a large state Medicaid perspective. BMC Health Serv Res 2012; 12: 459.
9. CDC, Centers of Disease Control and Prevention. Hepatitis C information for health professionals: statistics and surveillance, 2011. Available at: www.cdc.gov/hepatitis/HCV/StatisticsHCV.htm.
10. Smith BD, Beckett GA, Yartel A, Holtzman D, Patel N, Ward JW,. Previous exposure to HCV among persons born during 1945-1965: prevalence and predictors, United States, 1999-2008. Am J Public Health 2014; 104: 474-81.
11. Turner BJ, Taylor BS, Hanson JT, et al,. Implementing hospital-based baby boomer hepatitis c virus screening and linkage to care: Strategies, results, and costs. J Hosp Med 2015; 10: 510-6.
12. Younossi ZM, Kanwal F, Saab S, et al,. The impact of hepatitis C burden: an evidence-based approach. Aliment Pharmacol Ther 2014; 39: 518-31.
13. Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Ward JW,. Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention. Ann Intern Med 2012; 157: 817-22.
14. Denniston MM, Klevens RM, McQuillan GM, Jiles RB,. Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008. Hepatology 2012; 55: 1652-61.
15. Galbraith JW, Donnelly JP, Franco RA, Overton ET, Rodgers JB, Wang HE,. National estimates of healthcare utilization by individuals with hepatitis C virus infection in the United States. Clin Infect Dis 2014; 59: 755-64.
16. Younossi ZM, Zheng L, Stepanova M, Venkatesan C, Mishra A,. Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study. BMJ Open 2014; 4: e004318.
17. Medpac. The next generation of Medicare beneficaries. Report to the Congress: Medicare and the Health Care Delivery System 2015; 35-57. Available at: www.medpac.gov/documents/reports/chapter-2-the-next-generation-of-medicare-beneficiaries-(June-2015-report).pdf?sfvrsn=0.
18. Everhart JE, Ruhl CE,. Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas. Gastroenterology 2009; 136: 1134-44.
19. Sie L, Gatto NM, Bancroft E,. Hospitalizations due to hepatitis C in Los Angeles County, 2007-2009: case characteristics and factors associated with mortality. J Viral Hepat 2013; 20: 628-37.
20. Luo R, Greenberg A, Stone CD,. Increasing volume but decreasing mortality of hospitalized hepatitis C Patients in the United States, 2005 to 2011. J Clin Gastroenterol 2015; 49: 620-7.
21. Nguyen GC, Segev DL, Thuluvath PJ,. Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension. Clin Gastroenterol Hepatol 2007; 5: 1092-9.
22. Zalesak M, Francis K, Gedeon A, et al,. Current and future disease progression of the chronic HCV population in the United States. PLoS ONE 2013; 8: e63959.
23. Davis GL, Albright JE, Cook SF, Rosenberg DM,. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003; 9: 331-8.
24. Younossi ZM, Stepanova M, Mishra A, Venkatesan C, Henry L, Hunt S,. The impact of chronic hepatitis C on resource utilisation and in-patient mortality for Medicare beneficiaries between 2005 and 2010. Aliment Pharmacol Ther 2013; 38: 1065-75.
25. Krumholz HM, Nuti SV, Downing NS, Normand SL, Wang Y,. Mortality, hospitalizations, and expenditures for the medicare population aged 65 years or older, 1999-2013. JAMA 2015; 314: 355-65.
26. Kalra AD, Fisher RS, Axelrod P,. Decreased length of stay and cumulative hospitalized days despite increased patient admissions and readmissions in an area of urban poverty. J Gen Intern Med 2010; 25: 930-5.
27. Otgonsuren M, Henry L, Hunt S, Venkatesan C, Mishra A, Younossi ZM,. Resource utilization and survival among medicare patients with advanced liver disease. Dig Dis Sci 2015; 60: 320-32.
28. Davis GL, Roberts WL,. The healthcare burden imposed by liver disease in aging Baby Boomers. Curr Gastroenterol Rep 2010; 12: 1-6.
29. Galbraith JW, Franco RA, Donnelly JP, et al,. Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department. Hepatology 2015; 61: 776-82.
30. SSDH, Social Security Disability Help. Hepatitis and social security disability, 2014. Available at: http://www.disability-benefits-help.org/disabling-conditions/hepatitis-and-social-security-disability.
31. O'Malley KJ, Cook KF, Price MD, Wildes KR, Hurdle JF, Ashton CM,. Measuring diagnoses: ICD code accuracy. Health Serv Res 2005; 40: 1620-39.
32. CMS. ICD-10-CM/PCS the next generation of coding, 2015. Available at: https://www.cms.gov/Medicare/Coding/ICD10/downloads/ICD-10Overview.pdf.